Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Although Ozempic contains the same active ingredient as some weight loss medications, its use is strictly limited to diabetes management and cannot be prescribed through telehealth due to the need for in-person monitoring and testing
Injectable Wegovy has demonstrated approximately 15% weight loss in clinical trials, while Eli Lillys Zepbounda dual GIP/GLP-1 agonistshows approximately 21% weight loss at its highest dose
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer)
Research use only means in-vitro laboratory testing and controlled experimental protocols only
Ozempic Side Effects
Emerging clinical evidence suggests that GLP-1 receptor agonists may offer therapeutic benefits for patients with NAFLD
